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Abstract
Hemophilia A is a heterogeneous hemorrhagic disorder caused by a large num-
ber of mutations. Recurrent mutations are rare, except intron 22 and intron 1
inversions. The substitution of a cytosine to a thymine at nucleotide 6046 in F8
gene was identified in a group of Italian patients affected by hemophilia A from
a specific region of Northern Italy with a prevalence of 7.6%. This F8 variant
was the second most frequent mutation in our cohort, after the intron 22
inversion. The identification of the same mutation in a restricted population
gets to suppose the existence of a founder effect. Intragenic and extragenic
polymorphic markers were tested to assess this assumption. A peculiar haplo-
type in linkage disequilibrium with this recurrent mutation (c.6046C>T) was
identified in 71% of patients, supporting a founder effect. This distinctive hap-
lotype was not identified in a control group (Fisher’s exact test, P < 0.0001),
coming from the same geographic region. These data strongly suggested the
presence of a founder effect, supporting the existence of a single mutation
event. Using DMLE+2.3 software and the mathematical approach described by
Bengtsson and Thomson, the inferred age of this mutation is supposed to be
about 2325 years (95% CI: 904–5081) ago.
Introduction
Up to date, more than 100 X-linked inherited human dis-
orders or traits have now been identified, most of which
are classified as recessive (McKusick 1998). Among the
human X-linked recessive diseases, hemophilia A (HA;
MIM #306700) represents the most common hereditary
bleeding disorder, determined by decreased factor VIII
(FVIII) levels in plasma with a proportional reduction in
FVIII clotting activity (FVIII:C). FVIII is a plasma glyco-
protein with an essential role in the intrinsic coagulation
pathway, hence a deficiency or dysfunction of FVIII
causes limited and delayed generation of thrombin, with
defects in clot formation and consequent bleeding
diathesis. On the basis of residual FVIII:C, hemophilia
is categorized in three main forms: severe (FVIII:
C < 1 IU/dL), moderate (FVIII:C 1–5 IU/dL), and mild
(FVIII:C 6–39 IU/dL) (Mannucci and Tuddenham 2001).
The clinical picture of severe hemophilia patients is char-
acterized by frequent spontaneous bleeding episodes that
commonly occur into joints and muscles. Recurrent
hemarthroses may cause in these patients crippling
arthropathy on the long-term if not properly treated
(Mannucci and Tuddenham 2001).
The primary structure of FVIII was identified in the
early 1980s, when the protein was purified and its cDNA
has been cloned (Gitschier et al. 1984; Vehar et al. 1984).
A few years later, in 1986 by in situ hybridization experi-
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ments, the cytogenetic localization of the F8 gene (MIM
#300841; NC_000023.11) has been displayed in the proxi-
mal part of the long arm of the X chromosome (Xq28)
(Tantravahi et al. 1986). FVIII is synthesized as a single
polypeptide chain, containing 2332 amino acids arranged
within six domains organized as A1-A2-B-A3-C1-C2. The
molecule circulates in plasma as a heterodimer
(~300 kDa) composed of the two polypeptide chains.
(Vehar et al. 1984). The light chain, assembled by A3-C1-
C2 domains and a heterogeneous heavy chain consisted
of A1-A2-B domains. Immediately after release into circu-
lation, FVIII forms a tight noncovalent complex with von
Willebrand Factor (VWF) and the complex formation
allows to maintain physiological FVIII levels in the circu-
lation (Lenting et al. 1998).
Hemophilia A is a heterogeneous genetic disease associ-
ated with a large number of mutations. The most common
mutation, which occurs in 45–50% of patients with severe
hemophilia A, is the intron 22 inversion caused by an intra-
chromosomal homologous recombination between a
9.5-kb region in intron 22 (int22h-1) and either of two
extragenic, distal homologous, int22h-2 and int22h-3 dur-
ing meiosis (Lakich et al. 1993). Another common F8 gene
defect is the intron 1 inversion that causes 1–6% of all sev-
ere cases of hemophilia A (Bagnall et al. 2002).
The worldwide Factor VIII Variant Database,
(http://factorviii-db.org/), reports and includes 2015
unique mutations distributed uniformly across the entire
peptide chain of FVIII (updated October 2015). Point
mutations (missense, nonsense, and splice site mutations)
represent approximately 70% of the described molecular
defects in hemophilia A.
By screening hemophilia A patients followed at the
Angelo Bianchi Bonomi Haemophilia and Thrombosis
Center (Milan, Italy) (from 1998 to 2014), a recurrent
point mutation was identified in a large number of
patients coming from a specific region of Northern Italy.
The identification of the same mutation in patients from
a well-identified geographic region supports the hypothe-
sis of a founder effect. In this study, we address the ques-
tion whether this recurrent point mutation had a single
origin and, if so, when the mutational event had
occurred. To this end, we used the observed distribution
of allelic variants on disease and control chromosomes to
estimate the age of the mutation.
Materials and Methods
Subjects
A total of 364 patients from 317 not related families with
moderate/severe hemophilia A referred to the Angelo
Bianchi Bonomi Haemophilia and Thrombosis Center
(Milan, Italy) were recruited. From the same area of Italy,
96 subjects were recruited as control group. All subjects
involved gave their written informed consent according to
the Helsinki Declaration.
DNA extraction and FVIII gene analysis
DNA was extracted from leukocytes using standard salt-
ing-out procedure (Miller and Djkes 1988). Intron 22
inversion gene rearrangement was detected by long-range
PCR and performed as previously described (Liu et al.
1998). Intron 1 inversion detection was done by PCR, as
reported earlier (Bagnall et al. 2002). Coding regions,
intron/exon boundaries, and the 50 and 30 untranslated
regions of the F8 gene (NG_011403.1) were amplified by
PCR and sequenced by Sanger method using the ABI
Prism BigDyeTM Terminator Cycle Sequencing Ready
Reaction Kit (Applied Biosystem, Foster City, CA) on an
ABI PRISM 3130TM Genetic Analyzer (Applied Biosys-
tems). Data analysis was carried out with Software
Sequencing Analysis v3.0 (AB Applied Biosystems).
Sequence alignment was done using Basic Local Align-
ment Search Tool (http://blast.ncbi.nlm.nih.gov). All
oligonucleotides and PCR conditions are available on
request.
Nomenclature
Nucleotides are numbered from the first adenine in the
ATG initiator methionine codon, and amino acids are
numbered from 1 to 2351, starting with the first methion-
ine as +1. The mutations are reported following the
guidelines of the Human Genome Variation Society
(http://www.hgvs.org/mutnomen/recs.html).
Microsatellite analysis
For haplotype analysis, six polymorphic microsatellite
markers have been selected. Three markers are within
intron 13, 22, and 25 (STR13, STR22, and STR24) (San-
chez-Garcia et al. 2005; Liang et al. 2009) in F8 and three
extragenic markers (DXS7423, DXS1073, and DXS1108)
(Edelmann et al. 2002; Sanchez-Garcia et al. 2005; Fimi-
ani et al. 2006) flanking F8 gene. All microsatellite mark-
ers are located in the same chromosome X region, Xq28
(Fig. 1). Markers details are described in Table 1.
Polymerase chain reaction (PCR) was performed using
fluorescent end-labeled PCR primers, a HEX-labeled
oligonucleotide for DXS1073, a FAM-labeled oligonu-
cleotide for DXS1108, DXS7423, and STR22, and AT565-
labeled oligonucleotide for STR13 and STR24. PCR
products were analyzed by capillary electrophoresis in an
ABI PRISM 3130TM Genetic Analyzer (Applied Biosys-
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tems). Sizing was performed with ABI GeneMapper 4.0
(Applied Biosystems).
Allelic association and linkage analyses
Differences in allele proportions between disease and nor-
mal chromosomes were analyzed using Z-test to deter-
mine whether the differences observed were significant.
The probability associated with the Z-score was assessed
and the statistical threshold was set at 0.05.
To evaluate the allelic association between the mutation
and the original associated loci, the degree of linkage dis-
equilibrium (d) was assessed as defined by Bengtsson and
Thomson d = (pD  pN)/(1  pN) (Bengtsson and
Thomson 1981), where pD is the frequency of the associ-
ated allele on disease chromosomes and pN the frequency
of the same allele on normal chromosomes. The linkage
analysis was performed using the LOD score test
developed by Newton E. Morton (Morton 1955) and
described in detail by Strachan and Read. The LOD score
test compares the likelihood of obtaining the test data if
the two loci are linked (h < 0.5), to the likelihood of
observing the same data if the two loci are unlinked
(h = 0.5). Positive LOD scores favor the presence of link-
age, whereas negative LOD scores indicate that linkage is
less likely. By convention, a LOD score >3.0 is considered
evidence for linkage, as it indicates 1000 to 1 odds that
the linkage being observed did not occur by chance. On
other hand, a LOD score less than 2.0 is considered evi-
dence to exclude linkage. The LOD score is calculated as
follows LOD = Z = log10(1  h)NR(h)R/0.5(NR + R)
where NR denotes the number of nonrecombinant off-
spring, and R denotes the number of recombinant off-
spring. A series of LOD scores are obtained using
different linkage distances, and the maximum likelihood
was estimated for the recombination fraction hmax.
Estimation of the mutation age
Estimation of the c.6046C>T mutation age was carried
out using the DMLE+2.3 software (Reeve and Rannala
2002) (http://www.dmle.org/). This software uses the
Markov chain Monte Carlo algorithm for Bayesian infer-
ence of mutation age based on the observed linkage dise-
quilibrium at multiple genetic markers. The estimation of
the mutation age is based on the following parameters:
the observed haplotypes (or genotypes) in subjects with a
specific mutation and in normal subjects, map distances
among markers and position of the mutation relative to
markers, the estimated population growth rate (r), and an
estimate for the proportion of mutation-bearing chromo-
somes (f).
A second mathematical approach, described by Bengts-
son and Thomson (Bengtsson and Thomson 1981), was
used to confirm our findings. This is a moment method
based on the linkage disequilibrium (d), and the recombi-
nation frequency (h), as expressed in the algorithm
g^ = log d/log(1  h), where g^ is the age of the mutation
Figure 1. Genomic map of chromosome X: localization and position
of F8 gene and polymorphic markers on Xq28.
Table 1. Position (Mb), type of repeat, fragment length (bp) of sequence PCR fragment, numbers of alleles and heterozygosity rate (HR) of extra-
genic and intragenic polymorphic markers.
UniSTS Marker Xq band Position (Mb) Type of repeat Fragment length (bp) Alleles (n) Heterozygosity rate (HR) %
99583 DXS7423 Xq28 149.71 TCCA 175–199 7 N.A.
53337 DXS1073 153.82 TG 120–146 8 70.7
STR24 154.07 GT 178–196 5 38
STR22 154.10 GT 198–210 4 46.3
STR13 154.16 TG 148–164 6 46.3
147826 DXS1108 154.86 CA 160–177 6 65.9
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expressed as the number of generations. The Luria–
Delbr€uck correction was applied to this method to avoid
the risk of underestimation (Luria and Delbruch 1943).
Results
A total of 364 patients from 317 not related families with
moderate/severe hemophilia A were first screened for
common F8 inversions. In this patient population, the
prevalence of intron 22 inversion and intron 1 inversion
was 33.4% (106/317) and 1.9% (6/317), respectively.
Inversion-negative samples (64.7%, 205/317) were charac-
terized by direct sequencing of all coding regions and
intron-exon boundaries of the F8.
A recurrent point mutation c.6046C>T (NM_000132.3;
p.R2016W, NP_000123.1) was identified in 45 patients
belonging to 24 not related families (7.6%, 24/317) from
different Italian regions. Twenty-two families came from
Lombardy region (21 from Brescia, one from Milan), one
from Emilia Romagna, and one from Sicily (Fig. 2).
Patients carrying the c.6046C>T substitution have shown
variable FVIII:C ranging from <1 to 6 IU/dL.
Microsatellites analysis
To evaluate the hypothesis of a founder effect in our
patients carrying the recurrent mutation c.6046C>T, a
haplotype analysis was performed in all unrelated
patients (n = 24) and in a control group without the
recurrent mutation (n = 96). Five different haplotypes
were observed in 24 unrelated patients (Table 2). A
peculiar haplotype, defined as H1, characterized by fol-
lowed alleles 189, 128, 190, 206, 156, 171, was identi-
fied in the 71% (17/24) of patients with the recurrent
mutation. An additional haplotype (H2) differed from
H1 for the most distal marker, DXS7423, was identified
in 4/24 (17%) patients. All patients with H1 and H2
haplotype (21/24, 87.5%) were from specific area close
to Brescia, a city in Lombardy region, Northern of
Italy. Haplotype H3 differed from H1 for two extra-
genic markers, DXS1073 and DXS7423, and was identi-
fied in only one patient originating from Palermo.
Haplotype H4 was similar to the ancestral haplotype
H1 for two extragenic markers DXS1108 and DXS7423,
while H5 was totally different from ancestral haplotype.
None of the haplotypes associated with the c.6046C>T
mutation were present in 96 controls, coming from the
same geographic region (Fisher’s exact test, P < 0.0001).
Allelic association and linkage analyses
We analyzed also the frequencies of each marker allele
associated with the c.6046C>T and we compared them
with the corresponding allele frequency in the control
group (Table 3). The three alleles, 189, 128, and 171, cor-
responding to extragenic markers DXS7423, DXS1073,
and DXS1108, respectively, and contributing to the ances-
tral haplotype on the c.6046C>T chromosomes, occurs at
significantly increased frequency (P < 0.0001). A signifi-
cant difference in allele proportions, between patients and
Figure 2. (A) Geographic distribution of
patients carrying the mutation c.6046C>T in
Italy. (B) Geographic distribution of patients
carrying the mutation c.6046C>T in Lombardy.
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controls, also emerged for the allele 156 corresponding to
intragenic marker STR13, while not significant difference
emerged for alleles 206 and 190 associated to intragenic
marker STR22 and STR24, respectively.
The values of the linkage disequilibrium parameter (d)
for the six markers are given in Table 3. Considering the
intragenic markers, higher values of d were observed at
STR13 (allele 156, d = 0.833) and at STR22 (allele 206,
d = 0.758) loci than at STR24 (allele 190, d = 0.500).
Whereas, d is higher at the most proximal extragenic
locus DXS1108 (allele 171, d = 0.940) and decreases
slightly at DXS1073 (allele 128, d = 0.850), whereas it is
lower at the most distal locus DXS7423 (allele 189,
d = 0.704).
The LOD score analysis was performed between the
cluster of the three intragenic markers (STR24, STR22,
STR13), assumed as single locus, and between the extra-
genic markers DXS7423, DXS1073, and DXS1108. LOD
scores for each locus using different linkage distances
(h) and the estimate of the maximum likelihood for the
recombination fraction hmax are reported in Table 4.
The intragenic locus STR24/STR22/STR13 showed the
highest LOD score (12.69 at h = 0.08), the most proxi-
mal extragenic locus DXS1108 showed a maximum LOD
score of 5.41 at h = 0.04, which decreased for DXS1073
(3.29 at h = 0.12) and was lower for the most distal
locus DXS7423 (1.36 at h = 0.25) (Table 4). Higher val-
ues of LOD score were obtained with the cluster of the
three intragenic markers and with the proximal telom-
eric marker (DXS1108) indicating no cross over
occurred.
Estimation of the c.6046C>T mutation age
The DMLE+ software requires an estimation of the
population growth rate (r) and the proportion of
disease-bearing chromosome (f). The population growth
rate (r) was estimated by the following equation, as pre-
viously described1: T1 = T0e
(gr), in which T1 is the esti-
mated size of Italian population today (~60 million at
2012), T0 is the estimated size of the ancestral popula-
tion (~3 million at the beginning of 5th century before
Christ), and g is the number of generations between
these two time points (g = 100.48 considering 25 years
for a generation). Accordingly, population growth rate
was estimated to be approximately equal to 0.03. Using
a previously described method (Borroni et al. 2011), the
proportion of disease-bearing chromosomes was calcu-
lated by estimating the frequency of the c.6046C>T
Table 2. Haplotypes flanking the c.6046C>T mutation (NM_000132.3) in 24 Italian patients.
Haplotype DXS7423 DXS1073 STR24 STR22 c.6046C>T STR13 DXS1108 Frequency
H1 189 128 190 206 T 156 171 17/24 (71%)
H2 185 128 190 206 T 156 171 4/24 (17%)
H3 177 130 190 206 T 156 171 1/24 (4%)
H4 189 142 196 204 T 158 171 1/24 (4%)
H5 181 144 194 204 T 154 161 1/24 (4%)
Table 3. Linkage Disequilibrium between the c.6046C>T F8 mutation and markers in Xq28.
Marker (allele)
Ancestral allele proportions1 Difference in proportions
Linkage disequilibrium (d)2
pD pN 95% CIDp P value 95% CId
DXS7423 (189) 0.750 (18/24) 0.156 (15/96) 0.594 (95% CI: 0.405–0.781) <0.0001 0.704 (95% CI: 0.507–0.901)
DXS1073 (128) 0.875 (21/24) 0.167 (16/96) 0.708 (95% CI: 0.556–0.860) <0.0001 0.850 (95% CI: 0.692–1.000)
STR24 (190) 0.917 (22/24) 0.833 (80/96) 0.083 (95% CI: 0.050–0.216) 0.306 0.500 (95% CI: 0.362–0.638)
STR22 (206) 0.917 (22/24) 0.656 (63/96) 0.260 (95% CI: 0.114–0.407) 0.012 0.758 (95% CI: 0.606–0.909)
STR13 (156) 0.917 (22/24) 0.500 (48/96) 0.417 (95% CI: 0.267–0.566) <0.0001 0.833 (95% CI: 0.678–0.988)
DXS1108 (171) 0.958 (23/24) 0.302 (29/96) 0.656 (95% CI: 0.534–0.778) <0.0001 0.940 (95% CI: 0.815–1.000)
1pD and pN are the frequencies of the marker allele on disease-mutation bearing and normal chromosomes, respectively.
2Calculated according to the method of Bengtsson and Thomson: d = (pD  pN)/(1  pN).
Table 4. Maximum LOD SCORES between the c.6046C>T F8 muta-
tion and markers in Xq28.
Marker h1max Maximum LOD SCORE
2
DXS7423 0.25 1.36
DXS1073 0.12 3.29
STR13/STR22/STR24 0.08 12.69
DXS1108 0.04 5.41
1h < 0.5.
2LOD = Z = log10 (1  h)NR(h)R/0.5(NR + R) where NR and R are the
number of nonrecombinant and recombinant chromosomes, respectively.
LOD score >3 is evidence for linkage.
LOD score <2 is evidence to exclude linkage.
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mutation in the Italian male population (28 million):
considering the frequency of hemophilia A (1:5000 male
births) and giving a mutation frequency of 7.6% (24/
317), the proportion of disease-bearing chromosomes
was estimated to be 0.06.
Assuming that r = 0.03 and f = 0.06, analysis results
showed that the mutation c.6046C>T could be originated
93 generations ago (95% CI: 36–203), and considering
generations of 25 years, these data indicate that the
c.6046C>T mutation could be originated 2325 years ago
(95% CI: 904–5081), among 300 years before the com-
mon era (BCE) (Fig. 3).
When the mathematical algorithm g^ = logd/log(1  h)
(Bengtsson and Thomson 1981), was used and the Luria–
Delbr€uck correction (Luria 1945) was applied, assuming
that r = 0.03, the age of the mutation c.6046C>T was
estimated to be from 56 to 128 generations (1387–
3200 years) (Table 5).
Discussion
We identified a mutation of F8 (c.6046C>T) that is the
second most frequent in our patients affected by hemo-
philia A, after the intron 22 inversion with a prevalence
of 7.6%. This variant was identified in a group of patients
coming from a specific area close to Brescia, a city in
Lombardy region of Northern Italy. The high prevalence
of the mutation (c.6046C>T) in a restricted Italian popu-
lation is consistent with previous findings indicating that
the disease may be transmitted by founder effect in stable
populations with low inward migration (Winter et al.
2008). Haplotype analysis using intragenic and extragenic
microsatellites markers was employed to investigate the
hypothesis of a potential founder effect. A common
haplotype (H1), covering over 5.15 Mb in the region
Xq28 including F8 gene, was found in 71% of unrelated
patients with the recurrent mutation. An additional hap-
lotype (H2) different for the most distal marker
(DXS7423), was present in 17% of patients. This haplo-
type could probably be originated from the ancestral and
this could be explained by recombination events. Indeed,
the linkage parameters (hmax and LOD score) of this mar-
ker demonstrated the evidence of a higher likelihood for
the recombination event. However, it cannot be excluded
that some modifications could have originated by slippage
mispairing at the most distal marker DXS7423. Patients
sharing the H1 and H2 haplotype were from a specific
area close to Brescia and these combination of marker
alleles was not detected in any of the 96 Italian subjects
belong from the same Italian region of patients (Fisher’s
exact test, P < 0.0001).
The difference between the haplotype distribution in
patients and controls was confirmed when single marker
alleles associated with the mutation were analyzed, since
their frequency in patients was significantly higher than
that in controls, except for STR24 (allele 190). This allele
frequency was similar both in patients and controls,
according to low heterozygosity rate of STR24 in the gen-
eral population.
The region extended from DXS1108 to DXS7423 mark-
ers resulted to be in linkage disequilibrium showing a sta-
tistical association between the mutation and the six
Figure 3. Age estimation of c.6046C>T mutation calculated by the software DMLE+2.3. Distribution of the posterior probability as a function of
the age of c.6046C>T, assuming 0.06 as the proportion of disease-bearing chromosomes (f) and 0.03 as population growth parameter (r). In the
graph ‘Age of mutation’ is expressed as ‘number of generation’.
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alleles. The presence of a large region in linkage disequilib-
rium could be a result of founder effect and decreased alle-
lic diversity, typical features of isolated and stable
populations. In addition, LOD score analysis gave an evi-
dence of linkage between the mutation and the associated
loci. We can suppose that unrelated people with the disease
have actually inherited it from a distant common ancestor,
thus they tend to share particular ancestral alleles at loci
closely linked to the mutation locus. Moreover, two haplo-
types (H4 and H5) were found in patients coming from
other regions of Italy. Since the patients with the ancestral
haplotypes (H1) originate from one restricted geographic
area surrounding Brescia, we assume that they represent a
relatively isolated population with an extensive linkage dis-
equilibrium than outbred population. Then, the difference
between haplotypes H4 and H5 compared to ancestral may
arise from the diverge between populations over the course
of many generation or contrariwise that the mutation arose
later in a different population. To further evaluate whether
the recurrent mutation had a single origin and, in case,
when the mutational event has been occurred, an attempt
to estimate time to the origin of the mutation was per-
formed by the DMLE method and the mathematical algo-
rithm of Bengtsson and Thomson. Based on the DMLE
analysis, the c.6046C>T mutation was estimated to be
approximately 96 generations old, about 2100 years old
assuming 25 years per generation, and the mathematical
algorithm gave a similar result. These estimates place the
origin of the mutation during the II century before Christ
(BC), when north Italy was experiencing an heavy influence
from Celtic populations that, from 400 BC, descended in
North Italy and occupied Padana plain. Under Roman
Empire, from II century BC, Brescia, located in Padana
plain, became the most important center of tribe of Galli
(as roman called Celts) Cenomani that reached also pre-
Alpine mountains surrounding Brescia establishing their
tribe culture and maintaining their autonomy from
Romans.
Since almost all patients carrying the mutation origi-
nated from Brescia and showed a prevalent haplotype
associated with the mutation, it is tempting to speculate
that the common ancestor lived in a relatively isolated
area of Brescia, perhaps pre-Alpine area of Valtrompia,
from which the majority of patients came from. Thus, it
is plausible that the mutation frequency increased as a
result of a local founder effect and that low migratory
fluxes for long time favored the expansion of the muta-
tion in this area.
Furthermore, we cannot exclude that this mutation
might have spread far from Brescia due to more recent
migrations. It would be interesting to see whether the
other patients reported in Europe, Asia, America descend
from the same ancestor. Analysis of additional popula-
tions is required to definitely determine the origin and
the age of the ancestor allele.
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